Crispr Therapeutics Ag (CRSP) Stock Price, Quote & News

Company Profile

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR...

Industry: Biotechnology

Sector: Healthcare

Phone: 41 41 561 32 77

Website: www.crisprtx.com

Address:

Baarerstrasse 14, Zug, Switzerland

RideTheBu77 Jun. 26 at 8:00 PM

Meh - Low Volume. Given $CRSP history with the news and the epic last two weeks, it's fine. We'll need some type of new blood investors or institutions to bump the short interest.

0 · Reply

edu_simmons_2k Jun. 26 at 7:47 PM

$CRSP

0 · Reply

WallStreetBuyDip Jun. 26 at 7:16 PM

my entry for $CRSP will be when H% shows low like others here

0 · Reply

maaar Jun. 26 at 7:03 PM

$CRSP told you guys!!!!

0 · Reply

TargetsofInterest Jun. 26 at 6:36 PM

$CRSP There is still so much room for this to run. MACD is still low.

0 · Reply

BillyBlanks77 Jun. 26 at 6:34 PM

$CRSP shorts were hoping for a big sell the news pullback and didn’t get it. Gravity is taking us higher

0 · Reply

PhiloftheFuture Jun. 26 at 6:32 PM

$CRSP green close, big gap upcoming

0 · Reply

BitcoinMillionaire888 Jun. 26 at 6:27 PM

$CRSP $50+ will happen today, the news released will be used by those that understand to build a stake and one or two of the smarter shorts will now want out as soon as they can, but not enough shares avaialble so we all know what happens soon! Good luck!

1 · Reply

MidNi1Njf Jun. 26 at 6:13 PM

$CRSP

0 · Reply

elPresidente123 Jun. 26 at 5:19 PM

$CRSP added here lfg

2 · Reply

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

Jun 23, 2025, 12:01 PM EDT - 3 days ago

The Big 3: CRSP, OKLO, GME

OKLO GME

Jun 13, 2025, 6:27 PM EDT - 12 days ago

Crispr Therapeutics: Betting On A One-Shot Future

Jun 9, 2025, 5:50 PM EDT - 16 days ago

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Jun 3, 2025, 4:07 PM EDT - 22 days ago

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

May 29, 2025, 8:30 AM EDT - 4 weeks ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

May 9, 2025, 7:14 AM EDT - 6 weeks ago

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

May 8, 2025, 8:36 AM EDT - 7 weeks ago

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

May 7, 2025, 4:03 PM EDT - 7 weeks ago

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

May 7, 2025, 2:17 PM EDT - 7 weeks ago

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

May 7, 2025, 8:39 AM EDT - 7 weeks ago

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

May 6, 2025, 4:01 PM EDT - 7 weeks ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

May 5, 2025, 4:44 AM EDT - 7 weeks ago

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

NTLA

Apr 8, 2025, 3:29 PM EDT - 2 months ago

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

Apr 3, 2025, 8:00 AM EDT - 3 months ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 26, 2025, 4:01 PM EDT - 3 months ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

Mar 25, 2025, 11:03 AM EDT - 3 months ago

CRISPR Therapeutics Set To Reach Previous Heights

Mar 3, 2025, 3:28 PM EST - 4 months ago

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

Feb 26, 2025, 8:00 AM EST - 4 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 13, 2025, 11:06 AM EST - 4 months ago

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

Feb 11, 2025, 4:01 PM EST - 4 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 5, 2025, 4:16 PM EST - 5 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Feb 5, 2025, 3:48 PM EST - 5 months ago

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

Jan 15, 2025, 7:20 PM EST - 5 months ago

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

Jan 14, 2025, 7:39 PM EST - 5 months ago

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

Jan 8, 2025, 8:30 AM EST - 6 months ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 29, 2024, 12:56 PM EST - 6 months ago

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

Dec 9, 2024, 12:00 PM EST - 7 months ago

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

Nov 20, 2024, 9:28 PM EST - 7 months ago

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

Nov 15, 2024, 11:37 AM EST - 7 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

Nov 14, 2024, 8:30 AM EST - 8 months ago

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Nov 11, 2024, 12:54 PM EST - 8 months ago

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

Nov 5, 2024, 9:01 AM EST - 8 months ago

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 6:36 AM EDT - 8 months ago

Crispr Therapeutics: Poised For A Major Turnaround

Oct 6, 2024, 2:00 PM EDT - 9 months ago

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

AMGN BIIB BLUE BMY EDIT EXAS NTLA

Sep 18, 2024, 9:11 AM EDT - 10 months ago

Crispr Therapeutics: Prepare To Be Bored

Aug 14, 2024, 6:08 AM EDT - 11 months ago

Crispr's Casgevy Launch: Promising Start, Uncertain Future

Aug 7, 2024, 10:41 AM EDT - 11 months ago

Crispr Therapeutics Q2 Earnings: Casgevy Updates Underline 'Blockbuster' Potential

Aug 5, 2024, 4:01 PM EDT - 11 months ago

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Jul 7, 2024, 8:30 AM EDT - 1 year ago

Crispr Therapeutics: Beaten Down But Not Broken

Jun 11, 2024, 12:32 PM EDT - 1 year ago

CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript

Jun 10, 2024, 10:27 AM EDT - 1 year ago

Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis)

Jun 7, 2024, 6:26 PM EDT - 1 year ago

The 'Undercovered' Dozen From June 1-6

ALNY CLOV ENVX GAM HAL LPA PEO

Jun 6, 2024, 12:40 AM EDT - 1 year ago

CRISPR Therapeutics AG (CRSP) Jefferies 2024 Global Healthcare Conference (Transcript)

May 24, 2024, 7:40 PM EDT - 1 year ago

Final Trade: UAL, NKE, SLV & CRSP

SLV NKE UAL

May 23, 2024, 8:00 AM EDT - 1 year ago

CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

May 15, 2024, 4:12 PM EDT - 1 year ago

CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)

May 9, 2024, 8:30 AM EDT - 1 year ago

CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

May 8, 2024, 4:00 PM EDT - 1 year ago

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

May 8, 2024, 7:00 AM EDT - 1 year ago

CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach

RideTheBu77 Jun. 26 at 8:00 PM

Meh - Low Volume. Given $CRSP history with the news and the epic last two weeks, it's fine. We'll need some type of new blood investors or institutions to bump the short interest.

0 · Reply

edu_simmons_2k Jun. 26 at 7:47 PM

$CRSP

0 · Reply

WallStreetBuyDip Jun. 26 at 7:16 PM

my entry for $CRSP will be when H% shows low like others here

0 · Reply

maaar Jun. 26 at 7:03 PM

$CRSP told you guys!!!!

0 · Reply

TargetsofInterest Jun. 26 at 6:36 PM

$CRSP There is still so much room for this to run. MACD is still low.

0 · Reply

BillyBlanks77 Jun. 26 at 6:34 PM

$CRSP shorts were hoping for a big sell the news pullback and didn’t get it. Gravity is taking us higher

0 · Reply

PhiloftheFuture Jun. 26 at 6:32 PM

$CRSP green close, big gap upcoming

0 · Reply

BitcoinMillionaire888 Jun. 26 at 6:27 PM

1 · Reply

MidNi1Njf Jun. 26 at 6:13 PM

$CRSP

0 · Reply

elPresidente123 Jun. 26 at 5:19 PM

$CRSP added here lfg

2 · Reply

RideTheBu77 Jun. 26 at 5:11 PM

$CRSP They tried, (still trying) but good news, good week, good momentum. Dumbest stock to short, but they've had their fun for a few years. Now it's time to put this sp back up to $65+ where it belongs.

0 · Reply

burbs88 Jun. 26 at 4:33 PM

$CRSP Now that I've had a few drinks, let's forget about the roast and just slaughter these fat pigs alive with samurai swords!

0 · Reply

burbs88 Jun. 26 at 4:17 PM

$CRSP Doubt they leep it down today. Green end of day

0 · Reply

KillOrder Jun. 26 at 4:09 PM

$CRSP nothing but good coverage today but look at that the price is down a buck, dumb

0 · Reply

TargetsofInterest Jun. 26 at 3:47 PM

$CRSP The dip was massively bought. It was a short attack short covering. Shorts are toast. We have a lot more room to run based off the weekly chart. Even the monthly is show it has a reversal coming to far greater upside.

0 · Reply

Mambru500 Jun. 26 at 3:25 PM

$CRSP So we get positive phase 1 data for the number one cause of death in the US and the World 🌎 cardiovascular disease 🫀 🧠 and the stock is down 📉 🤣🤦‍♂️💆‍♂️ The title of this news should read we found how to cure the world

1 · Reply

maaar Jun. 26 at 3:16 PM

$SPY $NVDA $CRSP https://www.marketbeat.com/instant-alerts/crispr-therapeutics-crsp-buy-rating-reaffirmed-at-chardan-capital-2025-06-26/

0 · Reply

BitcoinMillionaire888 Jun. 26 at 3:06 PM

$CRSP got one more chunk of $10K leveraged cfd, will finish well over $50 today, the upgrade, if you read the actual wording why they have upgraded, will make your mouth water if you are long like myself 😁

0 · Reply

maaar Jun. 26 at 3:05 PM

$CRSP about to take off 🚀🚀🚀🚀🚀🚀

0 · Reply

RockitMann Jun. 26 at 2:53 PM

$CRSP shorts are going to run out of ammo this morning. Their attack is less potent than Iranians firing missles into Qatar.

0 · Reply

JarvisFlow Jun. 26 at 2:48 PM

Chardan Capital updates rating for CRISPR Therapeutics ( $CRSP ) to Buy, target set at 82.

0 · Reply

WallStreetBuyDip Jun. 26 at 2:45 PM

$CRSP Trading at $46.24, it's been quieter than usual with an average volume of 1.7M.

0 · Reply

Market Cap	4.04B
Revenue (ttm)	37.31M
Net Income (ttm)	-366.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-981.64%
Debt to Equity Ratio	0.00

Volume	2,040,583
Avg Vol	2,210,456
Day's Range	N/A - N/A
Shares Out	86.36M
Stochastic %K	91%
Beta	1.75
Analysts	Strong Sell
Price Target	$80.00